8
Participants
Start Date
December 31, 2005
Primary Completion Date
October 31, 2006
Study Completion Date
May 31, 2007
Glucagon-like-peptide-1 (7-36) amide
Continuous, subcutaneous GLP-1 at a dose of 4.8 pmol/kg/min for 51 hours
Placebo
continuous subcutaneous placebo infusion at a dose of 4.8 pmol/kg/min for 51 hours
Department of pharmacology, Aarhus university and Medical department M, Aarhus University hospital, Aarhus
University of Aarhus
OTHER